References
- World Health Organization. Medicines. Accessed: 12 January 2023. https://www.who.int/health-topics/medicines
- Besancon L, Chaar B. Report of the international summit on medicines shortage 2013. Final report. 2013:24. https://www.fip.org/files/fip/publications/FIP_Summit_on_Medicines_Shortage.pdf. Accessed 12 Jan 2023.
- World Health Organization. Addressing the global shortage of medicines and vaccines. WHA Resolution; Sixty-ninth World Health Assembly, 2016. WHA69.25. http://apps.who.int/medicinedocs/en/d/Js22423en/. Accessed 24 Nov 2022.
- Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing RMedicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysisLancet2009373240249 10.1016/s0140-.6736(08)61762-6.
- Tucker EL, Cao Y, Fox ER, Sweet BVThe drug shortage era: a scoping review of the literature 2001–2019Clin Pharmacol Ther202010811501155 10.1002/cpt.1934.
- Huys I, Simoens SEuropean drug shortages: a call for action!Int J Pharm Pract20132112 10.1111/ijpp.12012.
- Fink S. Drug shortages forcing hard decisions on rationing treatments. The New York Times. 29 January, 2016. http://www.nytimes.com/2016/01/29/us/drug-shortages-forcing-hard-decisions-on-rationing-treatments.html. Accessed 12 Jan 2023.
- Fox ER, Unguru YOncology drug shortages in the USA—business as usualNat Rev Clin Oncol202017128129 10.1038/s41571-.019-.0318-x.
- Choo EK, Rajkumar SVMedication shortages during the COVID-19 crisis: what we must doMayo Clin Proc20209511121115 10.1016/j.mayocp.2020.04.001.
- Cameron EE, Bushell MAAnalysis of drug shortages across two countries during pre-pandemic and pandemic timesRes Soc Adm Pharm20211715701573 10.1016/j.sapharm.2020.12.001.
- Chapuis C, Collomp R, Albaladejo L, et al.Redistribution of critical drugs in shortage during the first wave of COVID-19 in France: from operating theaters to intensive care unitsJ Pharm Policy Pract20221528 10.1186/s40545-.022-.00425-z.
- Miller FA, Young SB, Dobrow M, Shojania KGVulnerability of the medical product supply chain: the wake-up call of COVID-19BMJ Qual Saf2020 10.1136/bmjqs-.2020-.012133.
- De Weerdt E, Pauwels K, Preece D, et al.How should drug shortages be defined? A reviewEur J Hosp Pharm201522A75 10.1136/ejhpharm-.2015-.000639.179.
- Pharmaceutical Group of European Union (PGEU). Position paper on medicine shortages. https://www.pgeu.eu/publications/position-paper-on-medicine-shortages/. Accessed 12 Jan 2023.
- European Medicines Agency, Heads of Medicines Agencies. Good practice guidance for communication to the public on medicines’ availability issues. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guidance-communication-public-medicines-availability-issues_en.pdf. Accessed 12 Jan 2023.
- European Commission, Directorate-General for Health, Food Safety, et al. Future-proofing pharmaceutical legislation— study on medicine shortages. https://op.europa.eu/en/publication-detail/-/publication/e964d173-5320-11ec-91ac-01aa75ed71a1/language-en. Accessed 12 Jan 2023.
- McCartney MDaily drug shortages place avoidable pressure on primary careBMJ20153502514 10.1136/bmj.h2514.
- De Weerdt E, Simoens S, Casteels M, Huys IClinical, economic and policy implications of drug shortages in the European UnionAppl Health Econ Health Policy201715441445 10.1007/s40258-.016-.0264-z.
- European Medicines Agency, Heads of Medicines Agencies. European medicines agencies network strategy to 2025. https://www.ema.europa.eu/en/about-us/how-we-work/european-medicines-regulatory-network/european-medicines-agencies-network-strategy. Accessed 12 Jan 2023.
- Kozma CM, Reeder CE, Schulz RMEconomic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic researchClin Ther199315112132; discussion 1120
- Gunter MJThe role of the ECHO model in outcomes research and clinical practice improvementAm J Manag Care19995S217S224
- Fox ER, Sweet BV, Jensen VDrug shortages: a complex health care crisisMayo Clin Proc201489361373 10.1016/j.mayocp.2013.11.014.
- Caulder CR, Mehta B, Bookstaver PB, Sims LD, Stevenson BImpact of drug shortages on health system pharmacies in the Southeastern United StatesHosp Pharm201550279286 10.1310/hpj5004-.279.
- De Weerdt E, Simoens S, Casteels M, Huys ITime investment in drug supply problems by Flemish community pharmaciesFront Pharmacol20178568 10.3389/fphar.2017.00568.
- European Association of Hospital Pharmacists (EAHP). EAHP's 2014 survey of the medicines shortage problem. https://www.eahp.eu/practice-and-policy/medicines-shortages/2014-medicines-shortage-survey. Accessed Jan 2023.
- Katz M, Scherger J, Conard S, Montejano L, Chang SHealthcare costs associated with switching from brand to generic levothyroxineAm Health Drug Benefits20103127134
- Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RGSelegiline shortage: causes and costs of a generic drug shortageNeurology200973213217 https://doi.org/10.1212/WNL.0b013e3181ae7b04.
- Printz CCancer drug shortages lead to higher costs, greater riskCancer20131192667 https://doi.org/10.1002/cncr.28245.
- Atif M, Sehar A, Malik I, Mushtaq I, Ahmad N, Babar ZUWhat impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionalsBMC Health Serv Res202121827 https://doi.org/10.1186/s12913-.021-.06812-7.
- Phuong JM, Penm J, Chaar B, Oldfield LD, Moles RThe impacts of medication shortages on patient outcomes: a scoping reviewPLoS ONE201914 https://doi.org/10.1371/journal.pone.0215837.
- Shukar S, Zahoor F, Hayat K, et al.Drug shortage: causes, impact, and mitigation strategiesFront Pharmacol202112 https://doi.org/10.3389/fphar.2021.693426.
- Postma DJ, De Smet PAGM, Notenboom K, Leufkens HGM, Mantel-Teeuwisse AKImpact of medicine shortages on patients—a framework and application in the NetherlandsBMC Health Serv Res2022221366 https://doi.org/10.1186/s12913-.022-.08765-x.
- Postma DJ, De Smet PAGM, Gispen-de Wied CC, Leufkens HGM, Mantel-Teeuwisse AKDrug shortages from the perspectives of authorities and pharmacy practice in the Netherlands: an observational studyFront Pharmacol2018 10.3389/fphar.2018.01243.
- European Directorate for the Quality of Medicines & HealthCare. Standard Terms. https://standardterms.edqm.eu/. Accessed 12 Sep 2016.
- WHO Collaborating Centre for Drug Statistics Methodology. ATC—structure and principles. https://www.whocc.no/atc/structure_and_principles/. Accessed 12 Jan 2023.
- GBD 2017 Disease and Injury Incidence and Prevalence CollaboratorsGlobal, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet201839217891858 10.1016/s0140-.6736(18)32279-7.
- Z-index. About Z-Index. https://www.z-index.nl/english. Accessed 12 Jan 2023.
- Fox ER, McLaughlin MMASHP guidelines on managing drug product shortagesAm J Health Syst Pharm2018 10.2146/ajhp180441
- Musazzi U, Di Giorgio D, Minghetti P2SPD-030 How to assess the impact of medicines shortages in the European Union?Eur J Hosp Pharm202229A11A12 10.1136/ejhpharm-.2022-.eahp.23.
- Parenteral Drug AssociationRisk-based approach for prevention and management of drug shortagesPDA Tech Rep20146854
- European Medicines Agency. EU regulatory network reflection paper on the availability of authorised medicinal products for human and veterinary use. https://www.ema.europa.eu/documents/other/eu-regulatory-network-reflection-paper-availability-authorised-medicinal-products-human-veterinary_en.pdf. Accessed 12 Jan 2023.
- Urquhart JPharmacodynamics of variable patient compliance: implications for pharmaceutical valueAdv Drug Deliv Rev199833207219 https://doi.org/10.1016/S0169-.409X(98)00029-5.
- Ministry of Health Welfare and Sport. Medicine shortages and defects notification centre. https://www.medicineshortagesdefects.nl/. Accessed 12 Jan 2023.
- Ministry of Health Welfare and Sport. Bedrijven meldden in 2019 twee keer zoveel verwachte leveringsproblemen medicijnen [Companies reported twice as many expected supply issues in 2019]. https://www.meldpuntgeneesmiddelentekortendefecten.nl/actueel/nieuws/2020/04/09/bedrijven-meldden-in-2019-twee-keer-zoveel-verwachte-leveringsproblemen-medicijnen. Accessed 12 Jan 2023.